Dafydd Loughran

Prescribing costs are analysed by NHS managers in isolation of associated healthcare costs. So GPs are incentivised to prescribe cheaply. In asthma where short acting beta-2- bronchodilators (SABAs) are prescribed in excess, and at risk for patients, the costs increase exponentially with increased numbers of these SABAs per year. We analysed the costs in two published papers and present them in an easy to understand infographic- hopefully health care managers will now actively discourage excess SABAs and favour Inhaled Corticosteroids for all people with asthma - either as needed with formoterol or as part of a MART regime as per www.ginasthma.org. Asthma: effect of excess short-acting β2-agonist (SABA) inhaler prescriptions on healthcare resource utilisation https://lnkd.in/eZ6cAPsj

55

9 Comments

🔥 Don't Settle for Mediocrity in Spinal Surgery revenue! 🚀 🏥💪 Achieve Best Practice Tariff Uplift for the British Spinal Registry with Amplitude Clinical Outcomes and watch your revenue soar by 10%! 💰💼 Reach +50% compliance in the British Spinal Registry and unlock financial rewards. 📈💰 It's time to make a real impact! Amplitude Clinical Outcomes isn't just another system—it's a game-changer. Click the link to get started on your journey to healthcare excellence! #HealthcareRevolution #GameChanger #ROI #ChallengeYourself #BSR #uplift #revenue

3

What evidence do you need to launch a new product in the NHS? In this video, Dr Faris Al-Ramadani (Former PCN Clinical Director and GP Partner in the NHS, and HealthTech and Venture Capital Consultant) describes the sort of evidence that NHS decision-makers at different levels will be looking for. Faris highlights the importance of evidence that demonstrates how your solution can be implemented within the care pathway, in addition to its impact and the value that it can add. Here are just some of the questions NHS decision-makers may have: ❓ How do we implement this product? ❓ Which populations and communities will benefit? ❓ What impact will implementation have on other areas of the system? ❓ Where else in the system has it worked? ❓ How does it help the patient? ❓ How does it improve the quality of the service that the patient receives? ❓How does it drive efficiencies and/or free up resources... and how does this help the GP practice/hospital and wider ICB? For support generating and presenting such evidence, reach out to us today at [email protected] Watch the full webinar (first recorded in July 2024) at: https://lnkd.in/e4YuUNJb #NHSWhispers #GlobalWhispers #medtech #medicaldevices #pharma #healthtech

4

What evidence do you need to launch a new product in the NHS? In this video, Dr Faris Al-Ramadani (Former PCN Clinical Director and GP Partner in the NHS, and HealthTech and Venture Capital Consultant) describes the sort of evidence that NHS decision-makers at different levels will be looking for. Faris highlights the importance of evidence that demonstrates how your solution can be implemented within the care pathway, in addition to its impact and the value that it can add. Here are just some of the questions NHS decision-makers may have: ❓ How do we implement this product? ❓ Which populations and communities will benefit? ❓ What impact will implementation have on other areas of the system? ❓ Where else in the system has it worked? ❓ How does it help the patient? ❓ How does it improve the quality of the service that the patient receives? ❓How does it drive efficiencies and/or free up resources... and how does this help the GP practice/hospital and wider ICB? For support generating and presenting such evidence, reach out to us today at [email protected] Watch the full webinar (first recorded in July 2024) at: https://lnkd.in/e4YuUNJb #NHSWhispers #GlobalWhispers #medtech #medicaldevices #pharma #healthtech

2

🌟 Incredible feedback by Rima Makarem on the work the ShinyMind team are undertaking in transforming mental health services 🌟 🧠💡ShinyMind's innovative digital wellbeing prescription is truly revolutionary, supporting over 100 patients simultaneously - this is a game changer for the NHS's ability to support patients with mental health needs ➡️ Particularly inspiring was hearing Rima outlining their commitment, alongside ShinyMind to extend mental health support to young people and adolescents - a critical area of need 🎙️ The #VoicesofCare podcast highlights how digital innovation can create meaningful, scalable mental health solutions Take a listen below, and be inspired! ✨ #MentalHealthAwareness #DigitalHealth #Healthcare #Wellbeing #Innovation"

3

Submit an abstract for #RCRGlobalAI to showcase your work in front of clinicians from a range of specialties: 1️⃣ Communicate your AI projects as posters in-person and online 2️⃣ Share your achievements and influence practice in the UK and globally 3️⃣ Build your profile and have your work published 4️⃣ Earn additional CPD credits Find out more: https://bit.ly/4cywRFm #AI #ArtficialIntelligence #Education #Research

15

Three quarters (75%) of the public support sharing some of their personal health data for the development of AI systems in the NHS, according to a survey commissioned by think tank the Health Foundation. Interesting findings. Anything you do these days, you get asked for permission to share the data. This helps organisations understand their customers, and the healthcare sector is no exception. Although some individuals remain sceptical about data privacy, I believe we live in an era when data sharing is becoming more open. DPN Research discovered in 2022 that the younger generation is more likely to feel comfortable sharing their data, which actually makes real sense when you think about it. Back to the NHS, results show that 59% were willing to share data on areas such as their eye health, 58% on medicines they are taking, and 57% on long-term illnesses they live with. However, the percentage of phone-tracked data is lower, reaching 47%. People named the ability to see and talk to NHS staff as their most important consideration about technology use in healthcare, with 39% people aged 65 years and older naming this as their most important consideration. The poll found that around two-thirds of the public have either high or moderate levels of trust in the NHS with their health data. #digitalhealth #artificialintelligence #healthcareinnovation #healthcaretechnology

9

1 Comment

Introducing ICS® Dizcovery. Challenge expectations. Change Outcomes. ◼ Clinical precision. Rediscovered. ◼ A groundbreaking experience. ◼ A clearer clinical picture. ◼ Your partner for better outcomes. ◼ Natus Hearing and Balance UK&I

48

AI and Mixed Reality are revolutionising medical imaging, enabling intuitive analysis and interactive exploration of 3D images. Medicalholodeck AI enhances diagnosis and treatment through AI-powered segmentation and advanced visualisation, improving patient outcomes, and empowering medical education. This integration of AI and VR in healthcare not only reduces errors and costs but also transforms how medical professionals and patients engage with imaging technology. Thanks to Medicalholodeck for originally sharing this awesome innovation to LinkedIn

7

🌐 Understanding the NHS Acute Capacity Challenge 🌐 The NHS faces significant challenges in managing acute capacity. Our latest analysis covers: 🔹 Current issues and resource strains 🔹 Potential solutions and innovations 🔹 The role of technology in alleviating pressures https://lnkd.in/gh2nTR7Q

3

📚 Increase your knowledge and earn your accreditation with this on-demand webinar. Join as medical professionals from the US and the UK convene to talk about evolving the treatment landscape for gastroesophageal cancer. Watch the video, download the slides, and access the e-learning here https://ow.ly/PivO50Rh5X2 #MedEd #MedicalEducation #Oncology

7

September is #prostatecancer awareness month. #Prostate #cancer is a disease that kills 1 man every 45 minutes in the UK, a disease without #symptoms in its early, curable stages, and a disease that can affect men from middle age and does not only affect old men. A disease that we need to be proactive about to catch early, with state of the art precision #biopsy and #MRI. A disease that needs to be managed by expert #surgeons #oncologists #pathologists #radiologists and #nurse specialists as part of a multi-disciplinary #team like we have at Cleveland Clinic London And a disease that yes we have a month dedicated to raise awareness for, but that strikes all year round - regardless of whether it’s Christmas, Diwali, Hanukkah, or Eid. Every day of every month is a day for raising prostate cancer awareness in my book. If you are a man over 40 please check your risk of prostate cancer using the Prostate Cancer UK calculator and go and see your #doctor or #urologist if you’re at risk. Thank you 🙏 to Cleveland Clinic London for the opportunity to share my thoughts on #prostate #cancer and other #urology conditions below 👇

40

5 Comments

Check out a new resource area for healthcare professionals on the #ThrombosisUK website which shares #VTE #RiskAssessment tools commonly used in the #UK including the newly validated #HULLScore for suspected #thrombosis in cancer patients. https://lnkd.in/eZujHviC Great to have these but we desperately need more research to better inform risk assessment and in areas where evidence is lacking - acute #psychiatric in-patients, first trimester #pregnancy +++

15